Effects of salmon calcitonin suppositories in the prevention of bone loss in oophorectomized women

F. Polatti, F. Perotti, G. P. Angelini, D. Vassellatti, I. Rapisardi

Research output: Contribution to journalArticlepeer-review

Abstract

To evaluate the efficacy of salmon calcitonin (sCT) suppositories in inhibiting postmenopausal bone demineralization and the tolerability of this formulation, we treated ten women oophorectomized in reproductive age with intrarectal sCT at the dose of 200 IU/day for 12 months postoperatively. Modifications of calcium and phosphate metabolism were quantified by measurements of vertebral and peripheral bone mineral content, serum alkaline phosphatase, and hydroxyprolinuria at baseline and at 6 and 12 months of treatment. Tolerability was assessed by recording the appearance of local or systemic side-effects. sCT suppositories were demonstrated to inhibit post-oophorectomy calcium loss, and tolerability was good.

Original languageEnglish
Pages (from-to)73-76
Number of pages4
JournalMaturitas
Volume18
Issue number1
DOIs
Publication statusPublished - 1993

Keywords

  • Bone loss
  • Oophorectomized women
  • Salmon calcitonin suppository

ASJC Scopus subject areas

  • Ageing
  • Obstetrics and Gynaecology

Fingerprint Dive into the research topics of 'Effects of salmon calcitonin suppositories in the prevention of bone loss in oophorectomized women'. Together they form a unique fingerprint.

Cite this